• SPX
  • $5,917.11
  • 0 %
  • $0.13
  • DJI
  • $43,408.47
  • 0.32 %
  • $139.53
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,076.44
  • -0.11 %
  • -$8.63
  • IXIC
  • $18,966.14
  • -0.11 %
  • -$21.33
Zoetis Inc. (ZTS) Stock Price, News & Analysis

Zoetis Inc. (ZTS) Stock Price, News & Analysis

Currency in USD Disclaimer

$175.65

$0.09

(0.05%)

Day's range
$173.83
Day's range
$177.4
50-day range
$169.31
Day's range
$200.33
  • Country: US
  • ISIN: US98978V1035
52 wk range
$144.8
Day's range
$201.92


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 8.15
  • Piotroski Score 7.00
  • Grade Overweight
  • Symbol (ZTS)
  • Company Zoetis Inc.
  • Price $175.65
  • Changes Percentage (0.05%)
  • Change $0.09
  • Day Low $173.83
  • Day High $177.40
  • Year High $201.92

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

  • Last Earnings 10/10/2024
  • Ex-Dividend for 5/16 Dividend 10/31/2024
  • Dividend Payable 12/03/2024
  • Today N/A
  • Next Earnings (Estimated) 02/11/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $230.00
  • High Stock Price Target $254.00
  • Low Stock Price Target $195.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $5.20
  • Trailing P/E Ratio 34.02
  • Forward P/E Ratio 34.02
  • P/E Growth 34.02
  • Net Income $2.34 B

Income Statement

Quarterly

Annual

Latest News of ZTS

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Zoetis Inc. Frequently Asked Questions

  • What were the earnings of ZTS in the last quarter?

    In the last quarter Zoetis Inc. earnings were on Monday, November, 4th. The Zoetis Inc. maker reported $1.58 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.12.

  • What is the Zoetis Inc. stock price today?

    Today's price of Zoetis Inc. is $175.65 — it has increased by +0.05% in the past 24 hours. Watch Zoetis Inc. stock price performance more closely on the chart.

  • Does Zoetis Inc. release reports?

    Yes, you can track Zoetis Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Zoetis Inc. stock forecast?

    Watch the Zoetis Inc. chart and read a more detailed Zoetis Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Zoetis Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Zoetis Inc. stock ticker.

  • How to buy Zoetis Inc. stocks?

    Like other stocks, ZTS shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Zoetis Inc.'s EBITDA?

    Zoetis Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Zoetis Inc.’s financial statements.

  • What is the Zoetis Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.2743445693, which equates to approximately 27.43%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Zoetis Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Zoetis Inc.'s financials relevant news, and technical analysis. Zoetis Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Zoetis Inc. stock currently indicates a “sell” signal. For more insights, review Zoetis Inc.’s technical analysis.

  • A revenue figure for Zoetis Inc. for its last quarter?

    Zoetis Inc. published it's last quarterly revenues at $2.39 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.